Sparian Biosciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2018-01-01
- Employees
- 1
- Market Cap
- -
A Phase 1, Randomized, Placebo-Controlled Safety and Tolerability Study Of Intravenous SBS-1000 in Healthy Adults
- First Posted Date
- 2023-02-10
- Last Posted Date
- 2023-02-10
- Lead Sponsor
- Sparian Biosciences, Inc
- Target Recruit Count
- 56
- Registration Number
- NCT05721287
- Locations
- 🇺🇸
Altasciences Clinical Kansas, Overland Park, Kansas, United States
© Copyright 2025. All Rights Reserved by MedPath